* Login   * Register * FAQ    * Search
It is currently Wed May 22, 2013 3:59 pm

All times are UTC - 6 hours


Post new topic Reply to topic  [ 1 post ] 
Author Message
PostPosted: Tue Jun 12, 2012 3:13 pm 
Offline
MODERATOR
User avatar

Joined: Thu Jan 27, 2005 7:10 am
Posts: 8424
Location: Greensboro North Carolina
Survival improved among elderly patients with non-small cell lung cancer (NSCLC) when they received combined chemotherapy and radiotherapy rather than radiotherapy alone, indicated the findings of a study conducted in Japan.

To assess whether radiotherapy plus carboplatin would result in longer survival than radiotherapy alone in elderly patients with advanced NSCLC, the Japan Clinical Oncology Group randomized 200 patients older than age 70 years with unresectable stage III disease to chemoradiotherapy or to radiotherapy alone. Specifically, the 100 members of the chemoradiotherapy group received a radiation dose of 60 Gy plus concurrent low-dose carboplatin (30 mg/m2 per day, 5 days per week, for 20 days).

At a median follow-up of 19.4 months, median overall survival for the chemoradiotherapy group was 22.4 months, compared with 16.9 months for the radiotherapy-only group. Although chemoradiotherapy was well tolerated, grade 3 and grade 4 hematologic toxic effects were more prevalent among those patients: Leucopenia occurred in 63.5% (61) of the chemoradiotherapy participants, but in none of the radiotherapy patients; neutropenia in 57.3% (55) of the chemoradiotherapy patients and none of the radiotherapy patients; and thrombocytopenia in 29.2% (28) of the chemoradiotherapy patients and just 2.0% (two) of the radiotherapy patients.

Grade 3 infection also was more common with chemoradiotherapy (occurring in 12.5%, or 12 patients) than with radiotherapy (4.1%, or four patients). Incidences of grade 3 and grade 4 pneumonitis and late lung toxicity were similar between groups. Seven treatment-related deaths occurred, in three chemoradiotherapy patients (3%) and four radiotherapy patients (4.0%).

Shinji Atagi, MD, of the Kinki-chuo Chest Medical Center in Osaka, Japan, and colleagues concluded in their report for The Lancet Oncology that combination chemoradiotherapy does in fact provide a clinically significant benefit over radiotherapy alone for a select group of elderly patients with locally advanced NSCLC, and that the combination treatment should be considered for this population.

_________________
April/03 My Wife Deborah, age 46, diagnosed adenocarcinoma NSCLC
1/20/2006 Admitted to hospital Respiratory distress
1/23/2006 Ran to the light and is waiting for us to be rejoined in the Kingdom Of Heaven Her journey is Over but mine lingers on for Now!!!
4/23/07 DEb is joined in Peace by her Puppy Dawg Daisy from Cancer
8/30/07 Got new Pup named Mocha!!

"No matter hnow much it hurts, No matter how alone you feel, Your friends will help you get through anything!!"
Scrubs!!!!Yes the comedy show!!!

The Reason I advocate
If you would like to see our family photos Click on this link!
http://deborah-wallin.memory-of.com/

My memory-of Link is good to go now if you want to see it!!


Top
 Profile  
 
Display posts from previous:  Sort by  
Post new topic Reply to topic  [ 1 post ] 

All times are UTC - 6 hours


Who is online

Users browsing this forum: No registered users and 1 guest


You cannot post new topics in this forum
You cannot reply to topics in this forum
You cannot edit your posts in this forum
You cannot delete your posts in this forum
You cannot post attachments in this forum

Search for:
Jump to:  
Powered by phpBB® Forum Software © phpBB Group
[ Time : 0.062s | 13 Queries | GZIP : Off ]